BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31266495)

  • 1. Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study.
    Bech AB; Clausen T; Waal H; Šaltytė Benth J; Skeie I
    BMC Health Serv Res; 2019 Jul; 19(1):440. PubMed ID: 31266495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17.
    Larney S; Jones NR; Hickman M; Nielsen S; Ali R; Degenhardt L
    Addiction; 2023 Aug; 118(8):1527-1539. PubMed ID: 36843415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
    Pearce LA; Min JE; Piske M; Zhou H; Homayra F; Slaunwhite A; Irvine M; McGowan G; Nosyk B
    BMJ; 2020 Mar; 368():m772. PubMed ID: 32234712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.
    Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L
    JAMA Psychiatry; 2021 Sep; 78(9):979-993. PubMed ID: 34076676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality, Causes of Death, and Predictors of Death among Patients On and Off Opioid Agonist Treatment: Results from a 19-Year Cohort Study.
    Skeie I; Clausen T; Hjemsæter AJ; Landheim AS; Monsbakken B; Thoresen M; Waal H
    Eur Addict Res; 2022; 28(5):358-367. PubMed ID: 35998586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non drug-related and opioid-specific causes of 3262 deaths in Scotland's methadone-prescription clients, 2009-2015.
    Gao L; Robertson JR; Bird SM
    Drug Alcohol Depend; 2019 Apr; 197():262-270. PubMed ID: 30875647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
    Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L
    Mol Psychiatry; 2019 Dec; 24(12):1868-1883. PubMed ID: 29934549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.
    Kimber J; Larney S; Hickman M; Randall D; Degenhardt L
    Lancet Psychiatry; 2015 Oct; 2(10):901-8. PubMed ID: 26384619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
    Geddes L; Iversen J; Wand H; Maher L
    Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder.
    Gottlieb DJ; Shiner B; Hoyt JE; Riblet NB; Peltzman T; Teja N; Watts BV
    Acta Psychiatr Scand; 2023 Jan; 147(1):6-15. PubMed ID: 35837885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
    Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
    Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.
    Brothers TD; Fraser J; MacAdam E; Morgan B; Webster D
    Drug Alcohol Rev; 2022 Feb; 41(2):430-434. PubMed ID: 34347327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada.
    Russolillo A; Moniruzzaman A; Somers JM
    PLoS Med; 2018 Jul; 15(7):e1002625. PubMed ID: 30063699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study.
    Durand L; O'Driscoll D; Boland F; Keenan E; Ryan BK; Barry J; Bennett K; Fahey T; Cousins G
    Addiction; 2020 Oct; 115(10):1867-1877. PubMed ID: 32034837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study.
    Paul LA; Bayoumi AM; Chen C; Kocovska E; Smith BT; Raboud JM; Gomes T; Kendall C; Rosella LC; Bitonti-Bengert L; Rush B; Yu M; Spithoff S; Crichlow F; Wright A; Watford J; Besharah J; Munro C; Taha S; Nosyk B; Strike C; Manson H; Kahan M; Leece P
    Addiction; 2023 Apr; 118(4):686-697. PubMed ID: 36401610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
    Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
    Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.